MÓDULO

4

Lección 15. Linfoma primario del sistema nervioso central y otras neoplasias
María Luisa Martínez Ginés, Ana Gómez Roldós

Servicio de Neurología. Hospital General Universitario Gregorio Marañón. Madrid

Referencias bibliográficas

  1. Zhang Y, Zhou DB. Primary central nervous system lymphoma: status and advances in diagnosis, molecular pathogenesis, and treatment. Chin Med J (Engl). 2020 Jun 20;133(12):1462-9. [Pubmed]
  2. Citterio G, Reni M, Gatta G, Ferreri AJM. Primary central nervous system lymphoma. Crit Rev Oncol Hematol. 2017 May;113:97-110. [Pubmed]
  3. Chukwueke UN, Nayak L. Central Nervous System Lymphoma. Hematol Oncol Clin North Am. 2019 Aug;33(4):597-611. [Pubmed]
  4. Batchelor TT. Primary central nervous system lymphoma: a curable disease. Hematol Oncol. 2019 Jun;37 Suppl 1:15-8. [Pubmed]
  5. Bradley WG, Daroff RB, Fenichel GM, Jankovic J. Volumen II: Trastornos Neurológicos. Parte 3. Enfermedades neurológicas. Capítulo 56. Cáncer y sistema nervioso. En: Bradley and Daroff's Neurology in Clinical Practice. Volumen II. 5.ª ed. Elsevier; 2015. pp. 1307-426.
  6. Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016 May 19;127(20):2375-90. [Pubmed]
  7. O'Neill BP, Decker PA, Tieu C, Cerhan JR. The changing incidence of primary central nervous system lymphoma is driven primarily by the changing incidence in young and middle-aged men and differs from time trends in systemic diffuse large B-cell non-Hodgkin's lymphoma. Am J Hematol. 2013 Dec;88(12):997-1000. [Pubmed]
  8. Constantin G. Chemokine signaling and integrin activation in lymphocyte migration into the inflamed brain. J Neuroimmunol. 2008 Jul 31;198(1-2):20-6. [Pubmed]
  9. Venetz D, Ponzoni M, Schiraldi M, Ferreri AJ, Bertoni F, Doglioni C, Uguccioni M. Perivascular expression of CXCL9 and CXCL12 in primary central nervous system lymphoma: T-cell infiltration and positioning of malignant B cells. Int J Cancer. 2010 Nov 15;127(10):2300-12. [Pubmed]
  10. Correia CE, Schaff LR, Grommes C. Central Nervous System Lymphoma: Approach to Diagnosis and Treatment. Cancer J. 2020 May/Jun;26(3):241-52. [Pubmed]
  11. Grommes C, DeAngelis LM. Primary CNS lymphoma. J Clin Oncol 2017;35(21):2410-8. [Pubmed]
  12. Bühring U, Herrlinger U, Krings T, Thiex R, Weller M, Küker W. MRI features of primary central nervous system lymphomas at presentation. Neurology. 2001 Aug 4;57(3):393-6. [Pubmed]
  13. Küker W, Nägele T, Thiel E, Weller M, Herrlinger U. Primary central nervous system lymphomas (PCNSL): MRI response criteria revised. Neurology. 2005 Oct11;65(7):1129-31. [Pubmed]
  14. Chan CC, Rubenstein JL, Coupland SE, Davis JL, Harbour JW, Johnston PB, et al. Primary vitreoretinal lymphoma: a report from an International Primary Central Nervous System Lymphoma Collaborative Group symposium. Oncologist. 2011;16(11):1589-99. [Pubmed]
  15. Kluin PM, Deckert M, Ferry JA. Primary diffuse large B-cell lymphoma of the CNS. En: Swerdlow SH, Campo E, Harris NL (eds.). World Health Organisation Classification of Tumours. Pathology and Genetics of Tumours of the Haematopoietic and Lymphoid Tissues. Lyon: IARC Press; 2008. pp. 240-1.
  16. Bruna J, Graus F, Fernández-Vega I, Mateos B, Zarranz JJ. Capítulo 21. Neurooncología. Tumores cerebrales. En: Zarranz JJ (coord.). Neurología. 6.ª ed. Elsevier; 2018. pp. 519-43.
  17. Ropper AH, Samuels MA, Klein JP. Capítulo 31. Intracranial Neoplasms and Paraneoplastic Disorders. En: Adams and Victor's Principles of Neurology. 10.ª ed. McGraw Hill; 2014. pp. 639-71.
  18. Wen PY, Huse JT. 2016 World Health Organization Classification of Central Nervous System Tumors. Continuum (Minneap Minn). 2017 Dec;23(6, Neuro-oncology):1531-47. [Pubmed]
  19. Wesseling P, Capper D. WHO 2016 Classification of gliomas. Neuropathol Appl Neurobiol. 2018 Feb;44(2):139-50. [Pubmed]
  20. Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol. 2021 Aug 2;23(8):1231-51. [Pubmed]
  21. Wang KY, Chen MM, Malayil Lincoln CM. Adult Primary Brain Neoplasm, Including 2016 World Health Organization Classification. Radiol Clin North Am. 2019 Nov;57(6):1147-62. [Pubmed]
  22. Komori T. The 2016 WHO Classification of Tumours of the Central Nervous System: The Major Points of Revision. Neurol Med Chir (Tokyo). 2017 Jul 15;57(7):301-11. [Pubmed]
  23. Gupta A, Dwivedi T. A Simplified Overview of World Health Organization Classification Update of Central Nervous System Tumors 2016. J Neurosci Rural Pract. 2017 Oct-Dec;8(4):629-41. [Pubmed]
  24. Ostrom QT, Wright CH, Barnholtz-Sloan JS. Brain metastases: epidemiology. Handb Clin Neurol. 2018;149:27-42. [Pubmed]
  25. Achrol AS, Rennert RC, Anders C, Soffietti R, Ahluwalia MS, Nayak L, et al. Brain metastases. Nat Rev Dis Primers. 2019 Jan 17;5(1):5. [Pubmed]